Copyright © Inderes 2011 - present. All rights reserved.

Midsona

13.50 SEK

+5.06 %

Less than 1K followers

MSON B

NASDAQ Stockholm

Food & Beverage

Consumer Goods & Services

+5.06 %
+19.47 %
+59.20 %
+59.20 %
+70.03 %
+49.67 %
+63.04 %
-83.73 %
-43.79 %

Midsona operates in the health and wellness industry and focuses on the manufacture and distribution of dietary supplements and health products. The company's products are aimed at individuals and retailers looking for healthy alternatives. The business is global with a primary presence in Europe. Midsona was founded in 1892 and is headquartered in the city of Malmö, Sweden.

Read more
Market cap
1.96B SEK
Turnover
2.1M SEK
Revenue
3.63B
EBIT %
1.6 %
P/E
192.86
Dividend yield-%
1.63 %
Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
24/4
2026

Interim report Q1'26

6/5
2026

General meeting '26

7/5
2026

Annual dividend

ShowingAll content types
Third party research

Midsona: Skipping down Sesame Street - ABG

* Q1e: flat organic growth and minor margin improvements * Risenta acquisition adds 3.5% to FY sales * Trading at '26e EV/EBITA of ~9.5x We expect a fairly uneventful Q1 We anticipate flat organic growth y-o-y in Q1'26e, implying sales of SEK 909m and...

Midsona

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Third party research

Midsona: Brighter days ahead - ABG

* Underlying performance indicative of a brighter '26e * '26e-'27e adj. EBITA up 5% * Trading at NTM EV/EBITA of 8x Solid underlying performance boosted by NRIs Q4 came in above expectations on all key items, but was especially strong on adj. EBIT (29...

Midsona
Third party research

Midsona: Closing the year in style - ABG

* Adj. EBIT 29% above estimates at SEK 47m * '26e could bring both organic and structural growth * Consensus EBIT revisions likely up h.s.d. Q4'25 report The Q4 report was materially better than expected on adj. EBIT. Sales amounted to SEK 933m (2% vs...

Midsona
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.